APRINOIA Therapeutics Announces Fast Track Designation Granted By U.S. FDA To APN-1607 (Florzolotau) For The Diagnosis Of Progressive Supranuclear Palsy

Media coverage

• Title	APRINOIA Therapeutics Announces Fast Track Designation Granted By U.S. FDA To APN-1607 For The Diagnosis Of Progressive Supranuclear Palsy
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	21/05/24
  Persons	Howard Fillit

• Title	APRINOIA Therapeutics Announces Fast Track Designation Granted By U.S. FDA To APN-1607 (Florzolotau) For The Diagnosis Of Progressive Supranuclear Palsy
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	20/05/24
  Persons	Howard Fillit